Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2009-07-14 Report Publication Anno…
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
DATE OF BOARD MEETING
Report Publication Announcement Classification · 95% confidence The document is an announcement from Uni-Bio Science Group Limited stating the date of a board meeting to approve and publish the annual results for the year ended 31 March 2009. It does not contain the actual annual results or financial data but merely informs about the upcoming board meeting where such results will be approved and published. The document length is short (1549 characters) and it is clearly an announcement rather than the report itself. According to the 'MENU VS MEAL' rule, this is a Report Publication Announcement (RPA) rather than the Annual Report (10-K).
2009-07-14 English
VOLUNTARY ANNOUNCEMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Uni-Bio Science Group Limited regarding the approval and grant awards for two drug development projects under a major state science and technology program in China. It does not contain financial statements, management discussion, or detailed financial data. The document is relatively short (3912 characters) and serves as a public announcement of achievements and project approvals rather than a formal financial or regulatory report. There is no indication that this is an annual report, interim report, earnings release, or any other detailed financial filing. It also does not fit into categories like board changes, voting results, or legal proceedings. Given the nature and length, this is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2009-07-08 English
VOLUNTARY ANNOUNCEMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Uni-Bio Science Group Limited regarding the initiation of a pre-clinical trial and progress of a Phase III clinical trial for a drug candidate. It contains no financial data, no regulatory form references, no voting results, no management changes, and no detailed financial or operational report. The document is relatively short (3188 characters) and serves as a public update on a clinical trial progress rather than a formal report or filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or any other financial or governance filings. It is an announcement of a corporate development, which aligns best with the Regulatory Filings (RNS) category as a general regulatory announcement that does not fit other specific categories.
2009-07-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2009
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30 June 2009, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related activities for Uni-Bio Science Group Limited. The content focuses on share capital changes and securities movements during a specific month, which is a regulatory filing requirement for listed companies to report share capital movements. It does not contain financial statements, earnings data, management discussion, or audit information. It is a periodic regulatory disclosure about share capital movements rather than a financial report or announcement of voting results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2009-07-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2009
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31 May 2009, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in the company's capital structure, including share issues, options granted, and other equity movements. There are no financial statements, earnings data, management discussion, or audit information. The document is a regulatory filing reporting monthly equity movements, typical for compliance with exchange rules. It is not an annual or interim report, earnings release, or management report. It is not a proxy, AGM material, or voting results announcement. The document fits best under Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes.
2009-06-02 English
GRANT OF SHARE OPTIONS
Share Issue/Capital Change Classification · 100% confidence The document is an announcement regarding the grant of share options by the company Uni-Bio Science Group Limited. It details the number of options granted, exercise price, validity period, and confirms that none of the grantees are directors or substantial shareholders. The document is relatively short (2338 characters) and is a formal announcement of a share option grant, which is a capital change event. It is not a full financial report, earnings release, or management discussion. It fits the category of Share Issue/Capital Change announcements, which include share option grants under the company's share option scheme. Therefore, the appropriate classification is 'SHA' (Share Issue/Capital Change).
2009-05-26 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.